1315. Ceftaroline Versus Vancomycin for the Treatment of Acute Pulmonary Exacerbations of Cystic Fibrosis in Adults

BACKGROUND: Methicillin-resistant Staphylococcus aureus (MRSA) is a prominent colonizer in cystic fibrosis (CF) patients that causes acute pulmonary exacerbation (APE). Vancomycin is the first line treatment for APE of CF; however, optimal alternatives remain poorly defined. The goal of this study w...

Descripción completa

Detalles Bibliográficos
Autores principales: Esquivel, Marc, Monogue, Marguerite, Smith, Greg, Finklea, James D, Sanders, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644527/
http://dx.doi.org/10.1093/ofid/ofab466.1507

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644527/
http://dx.doi.org/10.1093/ofid/ofab466.1507

Ejemplares similares